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Abstract
A wearable electrocardiogram (ECG) monitor is eva-
luated as heart rate variability (HRV) monitor. The de-
vice consists of an armband designed to be worn on the
left upper arm which provides 3 ECG channels based on 3
pairs of dry (no hydrogel) electrodes. Armband-ECG and
conventional-Holter-ECG signals were simultaneously re-
corded from 14 subjects during 5 minutes in supine posi-
tion. Spacial principal component analysis was used to
obtain a unique armband ECG signal in which the elec-
tromyogram contribution is attenuated. QRS complexes
were automatically detected. Five traditional HRV para-
meters were derived: SDNN, RMSSD, pNN50, and powers
within low frequency (LF, [0.04, 0.15] Hz) and high fre-
quency (HF, [0.15, 0.4] Hz) bands. The Pearson’s corre-
lation coefficient between the measurements from the arm-
band device and the measures from the Holter device was
computed. Results show very high correlations (1.0000,
0.9999, 0.9984, 1.0000, and 0.9999 for SDNN, RMSSD,
pNN50, and powers at LF and HF, respectively), sugges-
ting that the quality of armband-ECG signals is enough
to estimate HRV parameters during stationary movement
restricted conditions.
1. Introduction
Continuous monitoring of heart beat occurrences has a
wide range of applications, such as atrial fibrillation de-
tection [1]. The heart beat occurrences can be used to
derive the heart rate and its variability (HRV), extending
the range of applications including, e.g., epileptic sei-
zures detection [2], and stress level monitoring [3]. In
fact, HRV remains a powerful framework for non-invasive
assessment of the autonomic nervous system (ANS) [4]
which has been studied in a large number of applications
in the last decades. Continuous electrocardiogram (ECG)
monitoring is usually performed by using Holter monitors,
which are not convenient for a long-term daily monitoring
because they use uncomfortable obstructive leads, and wet
electrodes over the chest that cause skin irritation after few
days.
Aiming to overcome the above mentioned limitations of
the conventional Holter devices, a wearable armband de-
vice for ECG monitoring is being developed in our lab at
the University of Connecticut. This armband records three
ECG channels using three pairs of hydrophobic dry elec-
trodes [5], differentially, while it is being worn on the left
upper arm. This armband device is more convenient for
daily long-term recordings than conventional Holter mo-
nitors, since it causes no skin irritation and uses no leads.
However, using dry electrodes over the left upper arm re-
presents a more challenging setup than the conventional
Holter setup, which is based on wet electrodes over the
chest. The armband setup relies on electrodes that are pla-
ced very close to each other over main limb muscles which
usually generate powerful electromyogram signals, spe-
cifically from biceps and triceps. Furthermore, although
these electrodes have a good impedance matching with the
skin considering that they are dry electrodes, the impe-
dance matching of hydrogel wet electrodes is better.
Nevertheless, a pilot study suggested that the armband
device provides ECG signals with enough quality to obtain
a QRS-morphology-based respiratory rate estimation du-
ring laboratory-controlled movement restricted conditions
[6]. Complementing a continuous respiratory rate monito-
ring with a heart rate and HRV monitoring would extend
the range of applications including sleep studies [7], and it
would allow to improve a stress level estimation [8]. Ho-
wever, the armband device has been not been evaluated as
a HRV monitor. In this paper, a first approach to evaluate
the armband device as a HRV monitor during laboratory-
controlled no-movement conditions is presented, using a
Holter device available in the market as Gold Standard.
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Figure 1: Example of first principal component of the 3 armband ECG channels (xA(n)), Holter ECG channel (xH(n)), and
their associated inverse interval functions (dIIF(n)).
2. Methods
2.1. Data and signal preprocessing
The three armband-ECG signals were recorded from 14
subjects (10 male) during 5 minutes in supine position.
The armband was worn on the left upper arm and uses a
sampling rate of 1000 Hz. In order to have a reference, an
additional ECG signal was simultaneously recorded by a
Rozinn RZ 153+ (Glendale, NY, USA) Holter device avai-
lable in the market. Three ECG channels were recorded by
this Holter device using a sampling rate of 180 Hz.
All ECG signals were resampled to Fs = 250 Hz. The
sampling rate is a trade-off situation. The higher sampling
rate the higher computational cost and battery consump-
tion, while the lower sampling rate the lower time resolu-
tion. The value of 250 Hz was chosen because it is the
minimum recommended for calculating the classical HRV
indices [4]. Then, baseline was attenuated by a high-pass
filter with a cut-off frequency of 0.3 Hz, and power line
was attenuated by a non-linear technique described in [9].
A spatial principal component analysis (PCA) was per-
formed, and the first principal component was chosen as
the unique armband-ECG signal for further analysis. The
reason of this choice is that this first principal component
is expected to have an attenuated contribution of the elec-
tromyogram from the local muscles (mainly left biceps and
triceps) [10]. This signal is denoted xA(n) in this paper. In
parallel, a unique ECG channel was visually chosen from
the Holter device for each subject, based on the observed
signal-to-noise ratio. This signal is denoted xH(n) in this
paper. An example of these signals can be observed in Fig.
1.
2.2. Heart rate variability analysis
QRS complexes were automatically detected by an al-
gorithm based on the variable frequency complex demo-
dulation described in [11], and normal beats (nNi ) were
determined by the algorithm presented in [12]. Then, the









where the superscript “u” denotes that the signal is une-
venly sampled, as the normal beats occur non uniformly in
time. An evenly-sampled version of du
IIF
(n) was obtained
by cubic splines interpolation using a sampling rate of 4
Hz, and it is denoted dIIF(n) in this paper.
Two inverse interval functions were obtained: one from
xA(n), and another one from xH(n). As xA(n) and xH(n)
are obtained from two independent devices, they are not
synchronized in time. In order to synchronize them, their
relative delay was estimated from the cross correlation be-
tween their associated inverse interval functions computed
from the segment of 2 minutes occurring at the center of
the 5 analyzed minutes. The delay was estimated as that
lag at which the cross correlation is maximum, and then, it
was corrected accordingly.
Once the delay was corrected, the normal-beat-to-
normal-beat (NN) intervals were computed, and the fol-
lowing time-based HRV parameters were estimated as re-
commended in [4]:
• SDNN: Standard deviation of NN intervals during the 5
minutes.
• RMSSD: Root mean square of the successive differences










































































































Figure 2: Scatterplots of HRV parameters estimated from the armband (aA) versus those estimated from the Holter device
(aH) (first row), and the corresponding Bland-Altman plots (second row).
• pNN50: The proportion of pairs of successive NN inter-
vals that differ by more than 50 ms during the 5 minutes.
Subsequently, the power spectral density of dIIF(n) was
estimated by using the Welch Periodogram with a 1-
minute-length Hamming window and 50% of overlap.
Then, the powers within low frequency (LF, [0.04, 0.15]
Hz) and within high frequency (HF, [0.15, 0.4] Hz) bands
were computed by integrating this power spectral density
within the corresponding bands.
Additionally, the same HRV parameters (SDNN,
RMSSD, pNN50, and powers at LF and HF bands) were
computed also from xH(n) for using them as reference.
For each one of the studied HRV parameters, two es-
timations per subject were available: one from the arm-
band and one from the Holter. The Pearson’s correlation
coefficient ρ between the two devices was computed. In
addition, the corresponding Bland-Altman plots were also
computed.
3. Results
Scatterplots of HRV parameters estimated from the arm-
band versus those estimated from the Holter device are
shown in Fig. 2. Additionally, the corresponding Bland-
Altman plots are also shown. Table 1 shows the obtai-
ned Person’s correlation coefficients, and the limits of
agreement (LOA) obtained from the Bland-Altman plots.
4. Discussion
A wearable armband device which records ECG signals
has been evaluated as a HRV monitor during laboratory-
Table 1: Obtained inter-subject Pearson’s correlation (ρ)
coefficients between HRV parameters estimated from the
armband and those estimated from the Holter. In addition,
the limits of agreement (LOA) obtained from the corre-
sponding Bland-Altman plots are also shown.
ρ LOA (mean ± 1.96×SD)
SDNN 1.0000 3.76E-5 ± 4.75E-4 s
RMSSD 0.9999 1.41E-4 ± 9.82E-4 s
pNN50 0.9984 2.53E-1 ± 1.07 %
LF 1.0000 1.75E-3 ± 2.45E-2 s−2
HF 0.9999 6.72E-3 ± 5.03E-2 s−2
controlled no-movement conditions. The armband is worn
on the left upper arm and it incorporates three pairs of
dry (no hydrogel) electrodes which are used differenti-
ally to record three ECG channels. The armband is much
more convenient than a Holter device for long-term moni-
toring because it causes no skin irritation and it uses no ob-
structive leads. PCA was used to derive a unique armband
ECG channel in which the electromyogram component is
attenuated. A conventional Holter device available in the
market was used as reference.
QRS complexes were automatically detected and 5 clas-
sical HRV parameters were computed from them: SDNN,
RMSSD, pNN50, and powers at LF and HF bands. In or-
der to evaluate the agreement of the HRV parameters me-
asured from the armband with those measured from the
Holter device, the inter-subject Pearson’s correlation coef-
ficient was computed, and the corresponding scatterplots
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and Bland-Altman plots were performed.
Scatterplots show a clear linear relation between the
HRV parameters measured from the armband and those
measured from the Holter (see Fig. 2). This linear re-
lation is quantified by the obtained Pearson’s correlation
coefficients which were very close to 1 for the 5 studied
HRV parameters (see Table 1), demonstrating a very high
positive correlation. Furthermore, the limits of agreement
obtained from the Bland-Altman plots were at least one
order of magnitude lower than their mean value for the 5
studied HRV parameters.
These results suggest that there is an excellent
agreement between the HRV parameters measured from
the armband and those measured from the the Holter. Thus
these results indicate that the armband device is potentially
useful for certain applications such as stress level asses-
sment [8] and sleep studies [13]. However, the analysis
performed in this study is limited to healthy volunteers in
laboratory-controlled movement restricted conditions. Fu-
ture studies are needed in order to evaluate the armband as
a HRV monitor in specific applications, e.g., during daily
life for long-term monitoring applications such as stress le-
vel assessment, or during polysomnography for sleep stu-
dies.
5. Conclusions
Results suggest that the armband device can substitute
a Holter device for HRV monitoring during movement re-
stricted conditions. Future studies have to be elaborated to
assess the performance of the armband in specific applica-
tions.
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